Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?

Axelsson J, Wang X, Ketteler M, Qureshi AR, Heimbürger O, Bárány P, Lindholm B, Nordfors L, Stenvinkel P.

Am J Nephrol. 2008;28(4):669-76. doi: 10.1159/000121358. Epub 2008 Mar 13.

PMID:
18337634
2.

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.

Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L.

Kidney Int. 2005 Jun;67(6):2383-92.

3.

Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.

Cozzolino M, Biondi ML, Galassi A, Gallieni M, d'Eril GV, Brancaccio D.

Am J Nephrol. 2007;27(6):639-42. Epub 2007 Sep 11.

PMID:
17851232
4.

AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects.

Andersen G, Burgdorf KS, Sparsø T, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O.

Diabetes. 2008 May;57(5):1427-32. doi: 10.2337/db07-0558. Epub 2008 Mar 3.

5.

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU.

Diabetes Care. 2006 Apr;29(4):853-7.

PMID:
16567827
6.

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.

Am J Kidney Dis. 2007 Feb;49(2):237-44.

PMID:
17261426
7.

Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis.

Lehtinen AB, Burdon KP, Lewis JP, Langefeld CD, Ziegler JT, Rich SS, Register TC, Carr JJ, Freedman BI, Bowden DW.

J Clin Endocrinol Metab. 2007 Jan;92(1):345-52. Epub 2006 Oct 24.

PMID:
17062776
8.

Serum retinol-binding protein concentration and its association with components of the uremic metabolic syndrome in nondiabetic patients with chronic kidney disease stage 5.

Axelsson J, O'Byrne SM, Blaner WS, Carrero JJ, Bruchfeld A, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P.

Am J Nephrol. 2009;29(5):447-53. doi: 10.1159/000176534. Epub 2008 Nov 21.

PMID:
19023195
9.

Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.

Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P.

Am J Kidney Dis. 2006 Dec;48(6):916-25.

PMID:
17162146
10.

AHSG gene variation is not associated with regional body fat distribution--a magnetic resonance study.

Müssig K, Staiger H, Machicao F, Machann J, Hennige AM, Schick F, Claussen CD, Fritsche A, Häring HU, Stefan N.

Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):432-7. doi: 10.1055/s-0028-1103299. Epub 2009 Apr 8.

PMID:
19358088
11.

Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass.

Fiore CE, Celotta G, Politi GG, Di Pino L, Castelli Z, Mangiafico RA, Signorelli SS, Pennisi P.

Atherosclerosis. 2007 Nov;195(1):110-5. Epub 2006 Sep 29.

PMID:
17010978
12.

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J.

Lancet. 2003 Mar 8;361(9360):827-33.

PMID:
12642050
13.

α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.

Manolakis AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, Tiaka EK, Oikonomou K, Valotassiou VJ, Potamianos SP.

World J Gastroenterol. 2017 Jan 21;23(3):437-446. doi: 10.3748/wjg.v23.i3.437.

14.

Fetuin-A serum levels are not correlated to kidney function in long-lived subjects.

Bellia C, Tomaiuolo R, Caruso A, Sasso BL, Zarrilli F, Carru C, Deiana M, Zinellu A, Pinna S, Castaldo G, Deiana L, Ciaccio M.

Clin Biochem. 2012 Jun;45(9):637-40. doi: 10.1016/j.clinbiochem.2012.02.024. Epub 2012 Mar 9.

PMID:
22425942
15.

Association of AHSG gene polymorphisms with ischemic stroke in a Han Chinese population.

Ma S, He Z, Zhao J, Li L, Yuan L, Dai Y, Qiu J.

Biochem Genet. 2013 Dec;51(11-12):916-26. doi: 10.1007/s10528-013-9625-6. Epub 2013 Aug 2.

PMID:
23907641
16.

Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis.

Sato H, Kazama JJ, Wada Y, Kuroda T, Narita I, Gejyo F, Gao P, Yamashita H.

Intern Med. 2007;46(20):1685-91. Epub 2007 Oct 15.

17.

Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.

Geroldi D, Minoretti P, Bianchi M, Di Vito C, Reino M, Bertona M, Emanuele E.

Neurosci Lett. 2005 Oct 7;386(3):176-8.

PMID:
16002217
18.

Circulating Triglycerides and the Association of Triglycerides with Dietary Intake Are Altered by Alpha-2-Heremans-Schmid Glycoprotein Polymorphisms.

Robinson KN, Vazquez-Vidal I, Marques C, Andrade FCD, Aradillas-Garcia C, Teran-Garcia M; UP AMIGOS Team.

J Nutrigenet Nutrigenomics. 2017;10(3-4):75-83. doi: 10.1159/000478657. Epub 2017 Aug 31.

PMID:
28858873
19.

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.

Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE.

Nephrol Dial Transplant. 2005 Aug;20(8):1676-85. Epub 2005 May 17.

PMID:
15899935
20.

Supplemental Content

Support Center